Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of the National Cancer Institute

• Publication date

  2006-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JNCI/DJJ019PMID 16449677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patterns of care in carcinoma of the ovary

  2010cited by this paper
• Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.

  2006cited by this paper
• Management of early ovarian cancer.

  2004cited by this paper
• Cancer Statistics, 2004

  2004cited by this paper
• Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States.

  2003cited by this paper
• Utility of the SEER-Medicare Data to Identify Chemotherapy Use

  2002cited by this paper
• Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis.

  2001cited by this paper
• Development of a comorbidity index using physician claims data.

  2000cited by this paper
• Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients

  1999cited by this paper
• The Ovarian Tumor Index predicts risk for malignancy

  1999cited by this paper
• Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research.

  1997cited by this paper
• Patterns of care for women with ovarian cancer in the United States.

  1997cited by this paper
• Completeness of hospital cancer case reporting from the SEER program of the national cancer institute

  1995cited by this paper
• National survey of ovarian carcinoma part V. The impact of physician's specialty on patients' survival

  1993cited by this paper
• Potential for Cancer Related Health Services Research Using a Linked Medicare‐Tumor Registry Database

  1993cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper
• The impact of subspecialty training on the management of advanced ovarian cancer.

  1992cited by this paper
• Reasons for incomplete surgical staging in early ovarian carcinoma

  1991cited by this paper
• Reasons for incomplete surgical staging in early ovarian carcinoma.

  1990cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• Lymph node metastasis of ovarian cancer: A preliminary survey of 74 cases of lymphadenectomy

  1987cited by this paper
• Lymph node metastasis of ovarian cancer: a preliminary survey of 74 cases of lymphadenectomy.

  1986cited by this paper
• Misstaging of Ovarian Cancer

  1985cited by this paper
• Staging laparotomy in early ovarian cancer.

  1983cited by this paper

• Impact of chemotherapy provider specialty on outcomes in ovarian cancer.

  2025cites this paper
• Adnexal mass referral patterns in Gynecologic Oncology

  2025cites this paper
• Staging discordance in apparent early-stage ovarian neoplasms: prevalence, prognosis, and practical risk stratification

  2025cites this paper
• Surgery in Ovarian Cancer—Brazilian Society of Surgical Oncology Consensus

  2025cites this paper
• Correlation between clinical presentation with USG findings and per-operative findings of ovarian tumor

  2025cites this paper
• External validation of the IOTA two-step strategy in the preoperative characterization of ovarian masses.

  2025cites this paper
• Implementation of O-RADS Ultrasound Reporting System: A Quality Improvement Initiative

  2025cites this paper
• Clinical Evaluation of a Multi-Omic Diagnostic Model for Early-Stage Ovarian Cancer Detection

  2025cites this paper
• GIANT ENDOMETRIOID OVARIAN CANCER: THE ROLE OF DIAGNOSTIC IMAGING AND FIGO STAGING

  2025cites this paper
• Spotlight on Carcinosarcoma of the Ovary: A Scoping Review.

  2024cites this paper
• Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery

  2024cites this paper
• The Ovarian-Adnexal Reporting and Data System (O-RADS) US Score Effect on Surgical Resection Rate.

  2024cites this paper
• Validation of ADNEX and IOTA two‐step strategy and estimation of risk of complications during follow‐up of adnexal masses in low‐risk population

  2024cites this paper
• Infrastructural and public health awareness gaps for the diagnosis and treatment of ovarian cancer: A literature review

  2024cites this paper
• Vers une guérison… Nécessité d’un parcours médicochirurgical organisé sur l’ensemble du territoire

  2024cites this paper
• Utility of a Multi-Marker Panel with Ultrasound for Enhanced Classification of Adnexal Mass

  2024cites this paper
• ReClassification of Patients with Ambiguous CA125 for Optimised Pre-Surgical Triage

  2024cites this paper
• Risk Prediction Model for Surgical Complications and Predictors of Delay/Omission of Adjuvant Chemotherapy Post Primary Cytoreduction in Epithelial Ovarian Cancer

  2024cites this paper
• Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal mass.

  2024cites this paper
• Geographic Disparities in Potential Accessibility to Gynecologic Oncologists in the United States From 2001 to 2020

  2023cites this paper
• Executive Summary of the Ovarian Cancer Evidence Review Conference

  2023cites this paper
• Current uptake and barriers to wider use of the International Ovarian Tumor Analysis (IOTA) models in Dutch gynaecological practice.

  2023cites this paper
• O-RADS US v2022: An Update from the American College of Radiology's Ovarian-Adnexal Reporting and Data System US Committee.

  2023cites this paper
• Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer

  2023cites this paper
• Current Issues in the Management of Patients With Newly Diagnosed Advanced-Stage High-Grade Serous Carcinoma of the Ovary.

  2023cites this paper
• A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer

  2023cites this paper
• Survival prognosis model for elderly women with epithelial ovarian cancer based on the SEER database

  2023cites this paper
• Adnexal Lesion Imaging: Past, Present, and Future.

  2023cites this paper
• Urological procedures performed by gynecologists: Activity profile in a gynecological surgery department, 10-year observation cohort.

  2023cites this paper
• Impact of obesity on chemotherapy dosing of carboplatin and survival of women with ovarian cancer

  2023cites this paper
• Rationale and Methodologic Approach for Assessing Ovarian Cancer Treatment and Gynecologic Oncologist Involvement in the Midwest Region of the United States.

  2023cites this paper
• Association of Teaching Status and Mortality After Cancer Surgery

  2022cites this paper
• Disparities in gynecologic cancer incidence, treatment, and survival: a narrative review of outcomes among black and white women in the United States

  2022cites this paper
• Plasmonic Gold Chip for Multiplexed Detection of Ovarian Cancer Biomarker in Urine

  2022cites this paper
• Machine Learning analysis of high-grade serous ovarian cancer proteomic dataset reveals novel candidate biomarkers

  2022cites this paper
• Lesions of the Ovary and Fallopian Tube.

  2022cites this paper
• Patterns of Treatment and Outcomes in Epithelial Ovarian Cancer: A Retrospective North Indian Single-Institution Experience

  2022cites this paper
• Impact of care by gynecologic oncologists on primary ovarian cancer survival: A population-based study.

  2022cites this paper
• Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic Mass

  2022cites this paper
• Feasibility and ability of laparoscopy to predict respectability in ovarian cancer: A cohort study

  2022cites this paper
• Using Genomic Variation to Distinguish Ovarian High-Grade Serous Carcinoma from Benign Fallopian Tubes

  2022cites this paper
• Interreader Agreement and Intermodality Concordance of O-RADS US and MRI for Assessing Large, Complex Ovarian-Adnexal Cysts.

  2022cites this paper
• Response to treatment and prognostic significance of supradiaphragmatic disease in patients with high-grade serous ovarian cancer.

  2022cites this paper
• Association of Distance to Gynecologic Oncologist and Survival in a Rural Midwestern State

  2022cites this paper
• HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients

  2022cites this paper
• Feasibility and ability of laparoscopy to predict respectability in ovarian cancer: Review article

  2022cites this paper
• Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in Ontario

  2022cites this paper
• Current clinical application of serum biomarkers to detect and monitor ovarian cancer – update

  2021cites this paper
• Diagnostic Performance of International Ovarian Tumor Analysis Logistic Regression Model LR2 for Adnexal Masses Classification at a Tertiary Gynecology Center in Singapore

  2021cites this paper
• NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Ovarian Cancer, Version 2.2020

  2021cites this paper
• Modified HE4, CA125, and ROMA cut-off values and predicted probability of ovarian tumor in Chinese patients.

  2021cites this paper
• Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients.

  2021cites this paper
• Primary treatment of advanced ovarian cancer: how does the 'real world' practice?

  2021cites this paper
• Association of Teaching Status and Mortality After Cancer Surgery

  2021cites this paper
• Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients

  2021cites this paper
• BRCA-guided therapy of ovarian cancer

  2021cites this paper
• Rural residence is related to shorter survival in epithelial ovarian cancer patients.

  2021cites this paper
• Ultrasound evaluation of ovarian masses and assessment of the extension of ovarian malignancy.

  2021cites this paper
• Bowel resection performed by gynecologists - Outcomes and learning curves. Activity profile in a Gynecology Department: 7-year observational cohort.

  2021cites this paper
• [National certification for gynecological cancer surgery].

  2021cites this paper
• Disparities in the Management of Peritoneal Surface Malignancies.

  2021cites this paper
• Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

  2021cites this paper
• Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group

  2021cites this paper
• [A curriculum based certification of competence in gynaecologic surgical oncology].

  2021cites this paper
• Directive clinique no 403 : Évaluation initiale et prise en charge des masses annexielles

  2020cites this paper
• Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications

  2020cites this paper
• Comparative Effectiveness of Robotic-Assisted Surgery for Resectable Lung Cancer in Older Patients.

  2020cites this paper
• Studies on Category Prediction of Ovarian Cancers Based on Magnetic Resonance Images

  2020cites this paper
• Low-risk multivariate index assay scores, physician referral and surgical choices in women with adnexal masses

  2020cites this paper
• Guideline No. 403: Initial Investigation and Management of Adnexal Masses.

  2020cites this paper
• Diagnostic accuracy of serum insulin-like growth factor-binding protein 2 for ovarian cancer

  2020cites this paper
• Analysis of the relationship between hospital characteristics and survival in ovarian cancer: A historical cohort

  2020cites this paper
• Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study

  2020cites this paper
• Obesity and aggressive prostate cancer

  2020cites this paper
• Institutional results of OncoOVARIAN Dx - a novel algorithm for the preoperative evaluation of adnexal masses.

  2020cites this paper
• Comparison of IOTA three-step strategy and logistic regression model LR2 for discriminating between benign and malignant adnexal masses.

  2020cites this paper
• Patients’ subjective assessment as a decisive predictor of malignancy in pelvic masses: results of a multicentric, prospective pelvic mass study

  2020cites this paper
• Rural disparities in surgical care from gynecologic oncologists among Midwestern ovarian cancer patients.

  2020cites this paper
• The Volume-Outcome Paradigm for Gynecologic Surgery: Clinical and Policy Implications

  2020cites this paper
• An update on screening and prevention for breast and gynecological cancers in average and high risk individuals.

  2020cites this paper
• Laparoscopic ureteral reconstruction in gynaecological recurrent cancer surgeries: an initial case series study

  2020cites this paper
• Adnexal lesions: Imaging strategies for ultrasound and MR imaging.

  2019cites this paper
• The Abnormal Ovary: Evolving Concepts in Diagnosis and Management.

  2019cites this paper
• Rural centres do not have a higher prevalence of post‐operative complications than urban centres: a retrospective analysis of a mortality audit

  2019cites this paper
• Regionalization of care for women with ovarian cancer.

  2019cites this paper
• Pre-operative assesment of adnexal mass

  2019cites this paper
• Operative Therapie des frühen und fortgeschrittenen Ovarialkarzinoms

  2019cites this paper
• Neoadjuvant therapy in gynaecological malignancies: What pathologists need to know

  2019cites this paper
• Combining A Second-Generation Multivariate Index Assay with Ovarian Imaging Improves the Preoperative Assessment of An Adnexal Mass

  2019cites this paper
• Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer

  2019cites this paper
• Comparison of CA 125 alone and risk of ovarian malignancy algorithm (ROMA) in patients with adnexal mass: A multicenter study.

  2019cites this paper
• Carcinosarcoma of the Ovary: A Single-Institute Experience with Surgical Cytoreduction and Platinum-Based Chemotherapy

  2019cites this paper
• Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely

  2019cites this paper
• Relation between the number of board‐certified gynecologic oncologists per hospital and survival of cervical cancer

  2019cites this paper
• Prospective external validation of IOTA three‐step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two‐step strategy using simple‐rules risk

  2019cites this paper
• Diagnostic performance of CA 125, HE4, and risk of Ovarian Malignancy Algorithm for ovarian cancer

  2018cites this paper
• Outcomes of Hysterectomy Performed by Very Low-Volume Surgeons.

  2018cites this paper
• Patient, physician, and caregiver perspectives on ovarian cancer treatment decision making: lessons from a qualitative pilot study

  2018cites this paper
• Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness.

  2018cites this paper
• Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer

  2018cites this paper